Trialogics

Trialogics is a clinical trial technology company, now a part of YPrime, that provides a suite of eClinical solutions designed to streamline the management of clinical research. Their core offerings include Interactive Response Technology (IRT) for randomization and trial supply management (RTSM), electronic Clinical Outcome Assessment (eCOA), and electronic Informed Consent (eConsent). The company's platform is built to be flexible and scalable, catering to pharmaceutical, biotech, and CRO clients globally. By integrating various trial management tools into a single ecosystem, Trialogics aims to improve data accuracy, patient engagement, and overall operational efficiency. Following its acquisition by YPrime in late 2023, the company's technologies have been integrated to enhance YPrime's global clinical trial delivery capabilities.